AlphAIalphai — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · Biotechnology

$OBIO

Orchestra BioMed Holdings, Inc.

Insider trades
Price · $OBIOvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $OBIO in the last 7 days.

Insider · 30dAll trades →
Buys
—
0 txs
Sells
$61K
1 txs
Sherman Darren1× · $61K
10b5-1 plan100%
See all $OBIO insider activity →
Top stories · $OBIOMore →
JUN 23·SEC EDGAR 8-KLow

Orchestra BioMed Holdings, Inc. (OBIO): Submission of Matters to a Vote of Security Holders

Orchestra BioMed Holdings, Inc. (OBIO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001814114 0001814114 2026-06-23 2026-06-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Repor

APR 29·Stock Titan

RTW funds exercise 1.25M Orchestra BioMed (NASDAQ: OBIO) pre-funded warrants

RTW funds have exercised 1,250,032 pre-funded warrants of Orchestra BioMed (NASDAQ: OBIO) at $0.0001 per share on a cashless basis. This transaction resulted in the issuance of 1,250,000 shares to RTW, with 32 shares withheld to cover the exercise price. Following the exercise, the RTW funds indirectly hold 9,556,095 shares of common stock and 2,386,331 pre-funded warrants, while adhering to a beneficial ownership cap of 19.99%.

OBIO sentiment & insider activity

Recent OBIO coverage spans financial news, corporate actions and insider activity.

In the last 30 days, OBIO insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($61K). The most active reporter was Sherman Darren, See Remarks, with 1 filing. 100% of activity was filed under pre-arranged Rule 10b5-1 plans.

What's driving OBIO

  • Routine shareholder-meeting outcomes; limited direct implications for near-term fundamentals beyond governance/comp-plan housekeeping.

    SEC EDGAR 8-K · Jun 23, 2026

  • This is a disclosed insider open-market purchase, which can be read as mild bullish sentiment but is not a fundamental catalyst by itself.

    SEC EDGAR · Jun 2, 2026

  • RTW funds exercised approximately 1.25 million pre-funded warrants of Orchestra BioMed, increasing their indirect ownership to about 9.56 million shares, while maintaining a beneficial ownership cap of 19.99%. This indicates continued significant institutional interest but no immediate large-scale insider buying or selling that would suggest a major strategic shift.

    Stock Titan · Apr 29, 2026

  • RTW Investments increased their stake in Orchestra BioMed to 19.2% through warrant exercises, indicating strong institutional interest.

    Stock Titan · Apr 29, 2026

  • The announcement of inducement grants under Nasdaq Listing Rule 5635(c)(4) by Orchestra BioMed indicates ongoing company growth and strategic employee incentivization. This positive corporate action may support the company's stock performance.

    GlobeNewswire · Nov 26, 2025

alphai scores every news story that mentions OBIO with an AI model for sentiment and relevance, and aggregates insider trades from Orchestra BioMed Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $OBIO

Score
JUN 23$OBIOLowSEC EDGAR 8-K

Orchestra BioMed Holdings, Inc. (OBIO): Submission of Matters to a Vote of Security Holders

Orchestra BioMed Holdings, Inc. (OBIO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001814114 0001814114 2026-06-23 2026-06-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Repor

3 min read
APR 29$OBIOLowStock Titan

RTW funds exercise 1.25M Orchestra BioMed (NASDAQ: OBIO) pre-funded warrants

RTW funds have exercised 1,250,032 pre-funded warrants of Orchestra BioMed (NASDAQ: OBIO) at $0.0001 per share on a cashless basis. This transaction resulted in the issuance of 1,250,000 shares to RTW, with 32 shares withheld to cover the exercise price. Following the exercise, the RTW funds indirectly hold 9,556,095 shares of common stock and 2,386,331 pre-funded warrants, while adhering to a beneficial ownership cap of 19.99%.

2 min read
APR 29$OBIOMedStock Titan

Orchestra BioMed (OBIO) stake rises to 19.2% after RTW warrant exercise

RTW Investments and affiliated funds have increased their beneficial ownership in Orchestra BioMed Holdings to 19.2% after exercising pre-funded warrants. On April 27, 2026, RTW funds exercised pre-funded warrants for 1,250,032 shares on a cashless basis, resulting in 1,250,000 new common shares for Orchestra BioMed. This transaction, combined with additional exercisable warrants, means RTW Investments and Dr. Roderick Wong beneficially own 11,942,394 shares.

2 min read

Related tickers

More in Biotechnology